EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;33:947-948. doi:10.1016/j.ejcts.2008.01.043
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Narcis Hudorovic
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Hudorovic, N.
PubMed
Right arrow Articles by Hudorovic, N.
Related Collections
Right arrow Education
Right arrow Lung - transplantation
Right arrow Cardiac - pharmacology
Right arrow Cardiac - physiology


Letters to the Editor

Statins and perioperative management of patients undergoing cardiovascular surgery

Narcis Hudorovic*

Department of Endo and Vascular Surgery, University Hospital "Sestre Milosrdnice", Vinogradska 29, 10000 Zagreb, Croatia

Received 16 January 2008; accepted 25 January 2008.

* Corresponding author. Tel.: +385 1 46 40 774; fax: +385 1 38 62 292. (Email: narcis.hudorovic@zg.htnet.hr).

Key Words: Cardiovascular disease • Risk factors • Statins

The first 20% of the full text of this article appears below.

The extraordinary actuality of the article of Paraskevas [1] is my excuse for this letter. Patients presenting for major cardiovascular surgery represent a dynamic challenge for the surgeon that extends beyond the intricacies of the planned operation. These patients frequently suffer from other significant comorbidities such as diabetes, respiratory, renal disease and elevated cholesterol. The management of these patients has to address not only immediate perioperative management issues but also prevent the deterioration of coexisting disease.

The growing body of evidence for such patients confirms that aggressive comprehensive risk factor management improves survival, reduces recurrent events and the need for interventional procedures, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
K. I. Paraskevas
Reply to HudorovicWould a randomized controlled trial testing the effects of statins on patients undergoing cardiothoracic surgery be ethical?
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 948 - 948.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.